Press Releases<< Back
First Patient Enrolled in AlloSure Registry
AlloSure launched on
"I am excited to launch this innovative registry to assess longer term clinical outcomes for kidney transplant patients. While most transplant studies focus on 1 year outcomes, we are providing valuable insights with up to 3 year patient follow up.
Additionally, we are encouraging all participating centers to adopt a standardized testing protocol to enable better comparisons and analysis of the effects of new testing on outcomes," said
For more information, please visit: www.CareDx.com.
Forward Looking Statements
This press release contains forward-looking statements about our business, research, development and commercialization efforts, including statements regarding K-OAR enrollment and prospects. These forward-looking statements are based upon information that is currently available to us and our current expectations, speak only as of the date hereof, and are subject to numerous risks and uncertainties, including risks
associated with successful research, development and planned commercialization of our technologies, that are described in our filings with the
Chief Commercial Officer
News Provided by Acquire Media